Requisition must be signed by a healthcare provider. Please print and bring the requisition to your healthcare provider for signature.
SignateraSignatera is a genetics-based cancer test (molecular residual disease test - MRD). It is personalized to detect and monitor your cancer status by examining your unique tumour mutation profile. It can do this much sooner and more accurately compared to traditional diagnostic methods (e.g. imaging).
The Initial Test analyzes both tumour tissue and blood in order to identify this unique profile. This test is only ordered once at the beginning.
The Subsequent Test is a repeatable test used to accurately monitor for the presence or absence of the disease over time. It can only be ordered after the result of the Initial Test is reported to your oncologist. It analyzes only your blood (also known as liquid biopsy). The frequency of the Subsequent Test is determined by your oncologist (e.g. 3 times per year).
About Signatera™ Genetic Testing
Who is this test for?
Individuals who have already been diagnosed with cancer (solid tumours), and are seeking answers to the following questions:
- Is there cancer left in the body?
- Is additional treatment beneficial?
- Is the treatment working?
What is this test used for?
Identification and monitoring of solid tissue cancer status by analyzing the associated tumour(s).
Your oncologist will recommend one of these two tests below.
Blood Sample (Initial & Subsequent Tests)
Tissue Sample (Initial Test Only)
Test Turnaround Time
4 weeks (Initial Test)
1 week (Subsequent Test)
ON & BC - Payment via LifeLabs Online Store
All other provinces/territories - Payment via LifeLabs Genetics Customer Care Centre 1-84-GENE HELP (1-844-363-4357)
Must use Signatera blood kit provided at your oncologist appointment. Collection can be done at your appointment or at a Lifelabs community location (BC, ON, SK).